Canine Distemper Virus Infection: A Multisystemic Disease Overview in Domestic Dogs

Meet K. Pandya¹*, Suresh V. Mavadiya², Shruti H. Inamdar³, Arshi A. Vagh⁴, Avinash K. Bilwal⁵

¹ Post-graduate Scholar, Department of Veterinary Medicine, College of Veterinary Science and Animal Husbandry Kamdhenu University, Junagadh, Gujarat, India

² Assistant Professor, Livestock Farm Complex, College of Veterinary Science and Animal Husbandry Kamdhenu University, Junagadh, Gujarat, India

³ Post-graduate Scholar, Department of Veterinary Medicine, College of Veterinary Science and Animal Husbandry Kamdhenu University, Junagadh, Gujarat, India

⁴ Professor & Head, Department of Veterinary Medicine, College of Veterinary Science and Animal Husbandry Kamdhenu University, Junagadh, Gujarat, India

⁵ Assistant Professor, Department of Veterinary Medicine, College of Veterinary Science and Animal Husbandry Kamdhenu University, Junagadh, Gujarat, India

*Corresponding Author, email: pandyameetk@gmail.com, phone no. 6354123587

1. INTRODUCTION

Canine distemper is a highly contagious, multisystemic viral disease of dogs characterized by respiratory, gastrointestinal, and neurological involvement. Despite the availability of effective vaccines, it remains a significant cause of morbidity and mortality, particularly in unvaccinated and stray dog populations. The disease poses a global threat and affects not only domestic dogs but also a wide range of wild carnivores.

Canine distemper (CD) is caused by the canine distemper virus (CDV), which was first isolated in 1905 (Carre, 1905). It is a highly contagious viral pathogen responsible for severe and often fatal disease in both domestic animals and a wide range of terrestrial and aquatic wildlife species. CDV is taxonomically classified under the genus Morbillivirus within the family Paramyxoviridae (Griffin, 2001; Murphy et al., 1999).

The Morbillivirus genus also includes several other highly infectious viruses of veterinary and medical importance, such as measles virus (MV) and rinderpest virus (RPV). Members of this genus exhibit similar host tropism and tissue distribution patterns. Transmission primarily occurs through aerosol exposure and direct contact. Clinically, infections are characterized by pyrexia, serous nasal discharge, coughing, and a combination of respiratory and gastrointestinal manifestations, frequently exacerbated by secondary bacterial infections. A hallmark feature of morbillivirus infections is the induction of marked, transient immunosuppression, which significantly contributes to disease severity (Griffin, 2007).

2. ETIOLOGY

Canine distemper is caused by the canine distemper virus (CDV), which belongs to the genus Morbillivirus within the family Paramyxoviridae. The virus is enveloped and contains a single-stranded, negative-sense RNA genome. It shares close structural and antigenic relationships with other morbilliviruses, including measles virus and rinderpest virus. Owing to the presence of a lipid envelope, CDV is relatively fragile in the external environment and is readily inactivated by heat, drying, and commonly used disinfectants; however, it may remain viable for extended periods under cooler conditions.

Morphologically, CDV is a relatively large virus, measuring approximately 150–250 nm in diameter, and is characterized by a lipoprotein envelope surrounding its RNA genome (Swango et al., 1995).

3. MODE OF TRANSMISSION

Canine distemper virus (CDV) is predominantly transmitted via aerosolized respiratory secretions, making close contact between susceptible and infected animals the principal route of spread. Infected animals excrete the virus in nasal discharge, saliva, urine, and feces, thereby contaminating the immediate environment and facilitating transmission. Although indirect transmission through contaminated food, water, or fomites is possible, the virus is relatively fragile outside the host and does not persist for long under adverse environmental conditions.

A key epidemiological characteristic of CDV is that infected animals can shed the virus prior to the onset of clinical signs, enabling subclinical dissemination within populations. Viral shedding may continue for several weeks and, in some cases, can extend up to 60–90 days post-infection, significantly enhancing transmission potential. The incubation period typically ranges from approximately one week to one month. While less common, transplacental (vertical) transmission has also been documented, leading to infection in neonates. The primary source of infection remains direct contact between susceptible dogs and infected domestic or wild carnivores (Greene et al., 1990).

4. PATHOGENESIS

Following entry through the respiratory tract, canine distemper virus (CDV) initially replicates within lymphoid tissues, particularly those associated with the upper respiratory system. This primary replication is followed by systemic dissemination via viremia. During this early phase, the virus induces marked immunosuppression, often characterized by lymphopenia, which increases the host’s susceptibility to secondary bacterial and opportunistic infections.

Subsequently, CDV spreads to epithelial tissues and multiple organ systems, including the respiratory and gastrointestinal tracts, resulting in multisystemic involvement. Within approximately 9–14 days post-infection, the progression and severity of disease are largely determined by the strength of the host’s humoral and cell-mediated immune responses, as well as the virulence of the viral strain (Greene et al., 1990). In later stages, the virus may invade the central nervous system, leading to neurological manifestations that are often progressive and severe. A notable clinical feature associated with epithelial damage is hyperkeratosis of the nasal planum and footpads. This thickening gives rise to the term “hardpad disease,” a commonly used alternative name for canine distemper (Fig 5.1).

5. CLINICAL SIGNS

Peracute forms of canine distemper, characterized by sudden onset of fever and rapid death, are uncommon; however, the acute form of the disease is more frequently encountered. Following an incubation period of approximately 3–7 days, affected dogs typically develop a biphasic fever that may rise to around 41°C. This phase is commonly accompanied by anorexia, catarrhal discharges, conjunctivitis, depression and frequent salivation (Fig 5.2).

Clinical presentation of canine distemper varies, with some dogs showing primarily respiratory signs (coughing, bronchitis, bronchopneumonia) and others gastrointestinal signs (vomiting, watery diarrhea, dehydration). In some cases, neurological involvement develops later, characterized by behavioral changes, myoclonus, seizures, ataxia, and paresis. Disease severity depends on secondary infections, with mortality ranging from 30–80%. Surviving animals often exhibit permanent neurological sequelae, and in older dogs, chronic encephalitis may occur as a late complication (Fenner et al., 1987).

The clinical expression of canine distemper is determined by viral virulence, environmental factors, and the host’s immune status, with involvement of multiple systems including respiratory, gastrointestinal, integumentary, and nervous systems. Early infection is characterized by biphasic fever and malaise during the viremic phase. Immunosuppression, particularly leukopenia, increases susceptibility to secondary infections, complicating disease progression (Williams, 2001).

6. PHYSICAL DIAGNOSIS AND LABORATORY FINDINGS

In domestic dogs, acute generalized canine distemper (CD) is often diagnosed based on clinical history and characteristic signs, particularly in unvaccinated animals. In nondomestic species, although clinical signs may raise suspicion, definitive differentiation is required from other conditions presenting with respiratory, neurological, or gastrointestinal involvement, such as Rabies, Feline panleukopenia, Toxoplasmosis, Canine parvovirus, lead poisoning, and bacterial enteritis.

Certain physical findings, such as hyperkeratosis of the nasal planum, footpads, and eyelids, are particularly suggestive of infection in species like ferrets, mink, raccoons, and foxes. Additionally, occasional jaundice has been reported as a distinctive but uncommon feature associated with CDV infection.

Laboratory investigations are essential for confirmatory diagnosis and for excluding other diseases with similar clinical presentations. Although virus isolation can be performed, it is technically demanding and requires co-cultivation of lymphocytes from the suspected animal with receptor-expressing cell lines. Hematological and biochemical abnormalities may include absolute lymphopenia, regenerative anemia, hypoalbuminemia, and increased α- and γ-globulin levels (Swango, 1995). Cytological examination may reveal CDV inclusion bodies within the cytoplasm—and occasionally the nuclei—of peripheral blood cells, particularly lymphocytes. Similar inclusions can also be detected in conjunctival scrapings, although their presence is generally limited to the acute phase of infection. Thoracic radiography may demonstrate interstitial or alveolar lung patterns supportive of pulmonary involvement. Analysis of cerebrospinal fluid (CSF) may further aid in evaluating central nervous system involvement in advanced cases.

7. TREATMENT

There is no specific antiviral therapy available for canine distemper; therefore, management is primarily supportive and symptomatic. The main objectives of treatment are to maintain hydration, correct electrolyte imbalances, provide adequate nutritional support, and minimize secondary complications.

Supportive care includes the administration of balanced electrolyte fluids, parenteral nutrition when required, and antipyretics to control fever and improve patient comfort. Broad-spectrum antibiotics are commonly used to prevent or manage secondary bacterial infections that arise due to virus-induced immunosuppression. Good nursing care is essential for recovery and includes maintaining hygiene, proper feeding, and monitoring of clinical status (Creevy, 2013).

For gastrointestinal signs, antiemetics may be administered to control vomiting, while neurological manifestations are managed using anticonvulsants such as Diazepam or Phenobarbital. Analgesics may also be used to relieve discomfort. Adjunctive therapies, including immunomodulators and vitamin supplementation, may offer supportive benefits in some cases. The prognosis varies considerably depending on disease severity; animals with mild systemic involvement may recover, whereas cases with neurological complications often have a guarded to poor prognosis.

8. PREVENTION AND CONTROL

Vaccination remains the most effective strategy for preventing canine distemper. Puppies are typically vaccinated starting at 6–8 weeks of age, followed by booster doses every 3–4 weeks until 16 weeks, with subsequent periodic revaccination. Proper adherence to vaccination schedules is crucial for establishing long-term immunity.

Additional preventive measures include strict biosecurity practices such as isolation of infected animals, sanitation of living environments, and minimizing exposure to unvaccinated or stray animals. Population control measures, including mass vaccination campaigns and public awareness initiatives, are essential for reducing disease incidence, particularly in endemic regions.

9. PUBLIC HEALTH AND ZOONOTIC ASPECTS

Canine distemper is not considered a zoonotic disease and does not directly infect humans. However, humans can act as mechanical carriers, inadvertently facilitating the spread of the virus between animals. Its close with the measles virus makes it of scientific interest in comparative virology and disease evolution studies.

Understanding the molecular similarities between CDV and human morbilliviruses has contributed to advancements in vaccine development and viral pathogenesis research. Although it poses no direct threat to human health, its ecological and veterinary significance remains substantial.

10. REFERENCES

Fenner, F., Bachmann, P. A., Gibbs, E. P. J., Murphy, F. A., Studdert, M. J., & White, D. O. (1987). Paramyxoviridae. In F. Fenner, P. A. Bachmann, E. P. J. Gibbs, F. A. Murphy, M. J. Studdert, & D. O. White (Eds.), Veterinary virology (pp. 485–503). Academic Press. https://doi.org/10.1016/B978-0-12-253055-5.50031-1

Carre, Sur la maladie des jeuneschiens, AcadSciC, R (1905) 140: 689–690, 1489–1491

Griffin DE (2001); Edited by Knipe, D.M. Philadelphia, and PA. Lippincott Williams andWilkins “Measles virus”, In Fields Virology, 4th(eds.), pp. 1401-1441

 Griffin, D. E., Knipe, D. M., Howley, P. M., D. E. (2007): Lippincott Williams and Wilkins, Philadelphia, Pa,(Eds.). USA “Measles virus,” in Fields Virology vol. 5, pp. 1551–1585

Swango, L. J., Ettinger, S. J., and Feldman, E.C., Saunders, W.B. Co., Philadelphia, Pennsylvania.,(1995): Canine viral diseases. In(eds.): Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat. pp. 398–409.

Greene, G. E., Appel. M, J., Saunders. Philadelphia., Pennsylvania, W. B (1990): Canine distemper In: Greene, C. E., Infectious Diseases of the Dog and Cat. pp. 226–241.

Williams, E. (2001): Canine Distemper. In Infectious Diseases of Wild Mammals (Williams and Barker, (Eds.). Iowa State University Press, Ames, IO. P

Please follow and like us: